Uses of 5-FU and glucagon jointly used for preparing medicine for treating colorectal cancer and pharmaceutical composition

• Main Authors: TIAN GENG, JIANG WENGUO, ZHU YANPING, ZHOU YIZI, XU YUXUE, MI JIA, LIU XINGJIE, LI SHASHA, CHI XIAODONG, YANG CHUNHUA
• Format: Patent
• Language: Chinese; English
• Published: 06.12.2019
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention discloses uses of 5-FU and glucagon jointly used for preparing a medicine for treating colorectal cancer in a subject and a pharmaceutical composition used for treating the colorectal cancer in the subject. The pharmaceutical composition comprises 5-FU, glucagon, and a pharmaceutically acceptable excipient or carrier. According to the uses of the 5-FU and the glucagon jointly used for preparing the medicine for treating the colorectal cancer in the subject and the pharmaceutical composition used for treating the colorectal cancer in the subject, the 5-FU and the glucagon are jointly used for treating the colorectal cancer in the subject, development of a tumor can be significantly inhibited, and the effect of treating the colorectal cancer is improved. 本发明提供了5-FU和胰高血糖素联合用于制备治疗受试者的结直肠癌的药物的用途以及用于治疗受试者的结直肠癌的药物组合物。所述药物组合物包含5-FU和胰高血糖素以及药学上可接受的赋形剂或载体。本发明采用5-FU和胰高血糖素联合治疗受试者的结直肠癌，能够显著抑制肿瘤的发展，提高结直肠癌的治疗效果。